Skip to main content
. 2021 Jul 26;11:693234. doi: 10.3389/fonc.2021.693234

Figure 5.

Figure 5

Relationship between TLS signature and OS of patients with given mutation status of driver genes. (A) Differences in OS of patients with wild type (high group n = 326, low group n = 163) or mutant EGFR (high group n = 42, low group n = 22) between the two indicated groups; (B) Differences in OS of patients with wild type (high group n = 237, low group n = 108) or mutant KRAS (high group n = 94, low group n = 58) between the two indicated groups; (C) Differences in OS of patients with wild type (high group n = 302, low group n = 155) or mutant BRAF (high group n = 29, low group n = 11) between the two indicated groups; (D) Differences in OS of patients with wild type (high group n = 171, low group n = 74) or mutant TP53 (high group n = 160, low group n = 92) between the two indicated groups.